Clinical Trial Update: Arsenic Trioxide for Induction Therapy of Adult Patients With Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating arsenic trioxide as induction therapy for adult leukemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Leukemia | Phase 2 | Status: TERMINATED